Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Obstet Gynecol ; 52(6): 656-61, 1978 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-733132

RESUMO

During a 4-month period 265 women delivered by cesarean section were studied to determine what effect membrane rupture has on the incidence and severity of postoperative infection. There was a definite correlation between the duration of ruptured membranes and the incidence as well as severity of postoperative infections. Only 29% of women with intact membranes subsequently developed endometritis with pelvic cellulitis, in contrast to 85% of those whose membranes were ruptured for less than 6 hours. Wound and pelvic abscesses were encountered in less than 1% of women delivered with intact membranes, yet these complications developed in over 30% of women with membranes ruptured for less than 6 hours. The incidence of septicemia was four times greater in those women whose membranes were ruptured for less than 6 hours. Women with endometritis were treated with one of two empirical antimicrobial regimens chosen randomly. Intravenous penicillin and tetracycline was found to be as effective as, and perhaps slightly more effective than, the combination of intravenous penicillin and intramuscular tobramycin.


Assuntos
Antibacterianos/uso terapêutico , Cesárea/efeitos adversos , Infecção Puerperal/tratamento farmacológico , Abscesso/tratamento farmacológico , Abscesso/etiologia , Endometrite/tratamento farmacológico , Endometrite/etiologia , Membranas Extraembrionárias/microbiologia , Feminino , Humanos , Recém-Nascido , Trabalho de Parto , Penicilinas/uso terapêutico , Gravidez , Tetraciclina/uso terapêutico , Fatores de Tempo , Tobramicina/uso terapêutico
2.
Obstet Gynecol ; 47(3): 319-26, 1976 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-129716

RESUMO

The metabolic clearance rate of dehydroisoandrosterone sulfate (MCRDS) was determined prospectively in gravidas with and without chronic essential hypertension. In normotensive patients, the MCRDS increased in linear fashion throughout pregnancy. In patients with chronic essential hypertension the MCRDS also increased progressively, but at higher values than in normotensive subjects. In normotensive gravidas who ultimately developed pregnancy-induced hypertension, the MCRDS increased progressively at a higher level than in gravidas who remained normotensive until approximately 4 weeks prior to the onset of clinical symptoms, at which time the MCRDS slowly decreased. Similarly, in gravidas with chronic hypertension who developed superimposed pregnancy-induced hypertension, the MCRDS increased progressively at higher levels than all groups studied until approximately 4 weeks prior to onset of hypertension, when a progressive decline in the MCRDS began.


Assuntos
Desidroepiandrosterona/metabolismo , Hipertensão/metabolismo , Pré-Eclâmpsia/metabolismo , Complicações Cardiovasculares na Gravidez/metabolismo , Doença Crônica , Feminino , Humanos , Hidroxilação , Taxa de Depuração Metabólica , Paridade , Doenças Placentárias/complicações , Pré-Eclâmpsia/etiologia , Gravidez , Segundo Trimestre da Gravidez , Terceiro Trimestre da Gravidez , Estudos Prospectivos
5.
Am J Obstet Gynecol ; 125(7): 881-8, 1976 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-941942

RESUMO

Oral prostaglandin E2 (PGE2) was used alone or synergistically with intravenous oxytocin to induce labor in 84 women whose pregnancies were at high risk. A control group of 84 similar high-risk pregnancies where labor was induced with intravenous oxytocin alone was studied to compare the safety and efficacy of the two regimens. Oral PGE2 administration, combined with the synergistic effect of intravenous oxytocin, is safe for induction of labor in gravid women whose fetuses are at risk. Uterine polysystole, which is potentially dangerous, especially to the high-risk fetus, was not commonly encountered and only once was associated with transient fetal bradycardia. Uterine hypertonus was not encountered with PGE2; however, it did occur with oxytocin stimulation. Nausea and vomiting occurred in one third of the women treated with PGE2 but were well tolerated and required discontinuation of the drug in only one instance. There was no apparent advantage of using the combination PGE2 regimen in patients whose cervices were more favorable for induction of labor (Bishop score, 5 to 9). However, oral PGE2, used either alone or synergistically with oxytocin, appears twice as effective in inducing labor than was oxytocin alone in women in whom labor was considered to be "difficult to induce" (Bishop score, 0 to 4).


Assuntos
Trabalho de Parto Induzido , Complicações na Gravidez , Prostaglandinas E/administração & dosagem , Administração Oral , Adulto , Cesárea , Parto Obstétrico , Feminino , Humanos , Hipertensão/complicações , Recém-Nascido , Complicações do Trabalho de Parto , Ocitocina/uso terapêutico , Gravidez , Prostaglandinas E/efeitos adversos , Risco
6.
N Engl J Med ; 296(24): 1380-3, 1977 Jun 16.
Artigo em Inglês | MEDLINE | ID: mdl-404555

RESUMO

To evaluate guidelines for outpatient treatment of acute pelvic inflammatory disease recommended by the Center for Disease Control we studied 197 afflicted women. The women were treated either with tetracycline or with procaine penicillin and ampicillin, and 92% were subsequently seen at least once to assess efficacy of clinical and microbiologic treatment. Neisseria gonorrhoeae was isolated from the lower genital tract in 68% of these women, and although they had a quicker symptomatic response than those with nongonococcal infection (P less than 0.01), the two regimens were equally effective in producing clinical cure. However, subsequent identification of a pelvic abscess was 10 times more common in women from whom N. gonorrhoeae was not isolated. Therapy for pelvic inflammatory disease must be empirical since it is impossible to distinguish clinically between gonococcal and nongonococcal infection, and our data indicate that both regimens recommended by the Center for Disease Control are effective.


Assuntos
Ampicilina/administração & dosagem , Doença Inflamatória Pélvica/tratamento farmacológico , Penicilina G Procaína/administração & dosagem , Tetraciclina/uso terapêutico , Doença Aguda , Adulto , Ampicilina/uso terapêutico , Avaliação de Medicamentos , Quimioterapia Combinada , Feminino , Humanos , Injeções Intramusculares , Neisseria gonorrhoeae/isolamento & purificação , Doença Inflamatória Pélvica/etiologia , Penicilina G Procaína/uso terapêutico , Probenecid/administração & dosagem , Probenecid/uso terapêutico , Tetraciclina/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA